Could Cannabinoids Help Recovery After Open-Heart Surgery? | Research

The takeaway

A narrative review of preclinical evidence suggests cannabinoids, particularly CBD, could help manage pain, inflammation, and tissue damage after open-heart surgery, potentially reducing reliance on opioids for post-surgical pain.

Cardiac surgeons, anesthesiologists, and pain management specialists considering cannabinoid adjuncts.

CBD shows preclinical promise for managing pain, inflammation, and ischemia/reperfusion injury post-surgery

What the researchers found

Preclinical evidence suggests CBD has anti-inflammatory, analgesic, and neuroprotective properties relevant to post-cardiac surgery recovery. The endocannabinoid system plays a role in managing physiological processes disrupted by cardiopulmonary bypass, and CBD has shown promise in managing ischemia/reperfusion injury in preclinical models.

Why it matters

Post-cardiac surgery pain management relies heavily on opioids, which carry addiction and side effect risks. If cannabinoids can reduce opioid requirements while addressing inflammation and tissue protection, this could significantly improve surgical recovery.

The numbers in context

Key applications reviewed: pain management, immune response modulation, ischemia/reperfusion injury mitigation; CBD identified as most promising candidate

How the study worked

Narrative review of preclinical evidence on cannabinoids in the context of open-heart surgery complications including pain, systemic inflammation, and organ damage.

What this study cannot tell us

Entirely based on preclinical evidence. No clinical trials in cardiac surgery patients. Cannabinoid interactions with cardiac medications and anesthetics are poorly understood. Post-surgical patients are a complex, high-risk population for any new intervention.

How to read the evidence

Narrative review of preclinical evidence only. No clinical data in cardiac surgery patients.

When this study was published

Published in 2024.

The bigger picture

This represents a novel application area for cannabinoid therapeutics. The combination of anti-inflammatory, analgesic, and tissue-protective properties makes cannabinoids theoretically well-suited for post-surgical care, but the gap between preclinical promise and clinical reality remains large.

Questions still open

Would CBD interact with anticoagulants and other cardiac medications post-surgery?
Could cannabinoids reduce opioid requirements after cardiac surgery without compromising pain control?

Common questions

Can cannabinoids help after heart surgery?

Preclinical evidence suggests potential for pain relief, reduced inflammation, and tissue protection, but no clinical trials in cardiac surgery patients have been conducted.

Would this replace opioids?

The goal would be to supplement or reduce opioid requirements, not eliminate them entirely. But this remains theoretical.

Read the original research

Exploring the Possible Role of Cannabinoids in Managing Post-cardiac Surgery Complications: A Narrative Review of Preclinical Evidence and a Call for Future Research Directions.

Journal of cardiovascular pharmacology, 83(6), 537-546

View on PubMed ↗Publisher’s paper ↗

Citation

Pollak, Uri; Avniel-Aran, Adi; Binshtok, Alexander M; Bar-Yosef, Omer; Bronicki, Ronald A; Checchia, Paul A; Finkelstein, Yaron. (2024). Exploring the Possible Role of Cannabinoids in Managing Post-cardiac Surgery Complications: A Narrative Review of Preclinical Evidence and a Call for Future Research Directions.. Journal of cardiovascular pharmacology, 83(6), 537-546. https://doi.org/10.1097/FJC.0000000000001560